The Efficacy of PRUCARE Program and Pruritus

  • STATUS
    Recruiting
  • participants needed
    40
  • sponsor
    Hacettepe University
Updated on 16 February 2024
pharmacological treatment
skin disorder
liver disease
dermatosis
acquired immunodeficiency syndrome (aids)

Summary

The research will be conducted randomly in order to determine the effect of PRUCARE program structured according to the biopsychosocial itch model in the management of itch symptom.

Description

In this study, there will be three groups: intervention group 1 with training, counseling and autogenic relaxation (OR), intervention group 2 with training, counseling and virtual reality game application and control group with routine nursing care. The number of volunteers to be included in the study was determined by power analysis. Forty patients with itch symptoms will be included in each group. Preliminary application for all three groups will be performed in the patient group registered to the Dialysis Unit of the Nephrology Department of Hacettepe University and Baskent University Hospital. Socio-Demographic Form, 5-D Itch Scale, Visual Analogue Scale (VAS), Dermatology Life Quality Index, State and Trait Anxiety Scale, Pruritus Behavior and SGO / OR Application Log, Dietary Behavior of Hemodialysis Patients Scale, Hemodialysis Patients Diet Information Scale and Digital Skin Moisture Measurement Device will be used.

Details
Condition Pruritus, chronic renal insufficiency, Renal Failure, Renal Failure, Chronic renal failure, Dermatosis
Age 18years - 65years
Treatment prucare program
Clinical Study IdentifierNCT04289038
SponsorHacettepe University
Last Modified on16 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Receiving hemodialysis treatment for the last 6 months
Receiving four hour hemodialysis treatment three times a week
-65 years of age
experiencing pruritus for the last month
Not taking any pharmacological / non-pharmacological treatment for pruritus
No cognitive and psychiatric diagnosis
Do not use hearing aids
Open to communication and cooperation
Using smart mobile phone
Without liver disease and dermatological diseases
Patients who agree to participate in the study will be included in the study

Exclusion Criteria

Pregnant in the research process
Kidney transplantation
Experiencing discomfort due to virtual reality glasses
Patients who voluntarily leave the trial will be excluded from the follow-up
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.